Target intelligence / Profile preview

Beta radiation (β-radiation or β (beta))

Target
β-radiation or β (beta)
Molecular classification
Other (Ionizing radiation; not a protein, receptor, or enzyme)
01

Overview

Beta radiation consists of high-energy, high-speed electrons (beta minus, β–) or positrons (beta plus, β+) that are expelled from the nucleus of unstable atoms during the process of beta decay. Beta particles are moderately penetrating ionizing radiation: they can travel centimeters in air and millimeters in human tissue, posing an external hazard primarily to skin and superficial tissues, and a far greater internal hazard if beta-emitting materials are ingested or inhaled. Beta radiation is used therapeutically in medicine (e.g., radiopharmaceuticals that emit beta particles to target tumors), but it is not a druggable molecular target in the way proteins or receptors are. Its biological and clinical effects are mediated entirely through its physical ionizing interactions with cellular molecules, chiefly via the production of reactive free radicals and direct DNA damage. Excessive exposure causes burns, cellular mutation, and increases cancer risk. Beta radiation is characterized by intermediate ionizing capacity and penetration compared to alpha and gamma radiation.

Other names
Beta particleBeta rayβ-particleBeta emission
02

Mechanism of action

Beta radiation causes biological effects by ionizing atoms in tissues, leading to DNA damage and cellular injury.

03

Biological functions

Other (Causes ionization in matter and biological tissues; not a structured biological or physiological function as seen with proteins or receptors)
04

Disease associations

Other (Exposure can cause cell damage, mutations, skin burns, carcinogenesis. It is relevant in the context of radiation injury or cancer therapy with radioisotopes)
05

Safety considerations

Radiation burnsDNA damagetissue destructionmutagenesiscarcinogenesisparticular risk with internal exposure to beta-emitting isotopes

Beyond the preview

Go deeper on Beta radiation (β-radiation or β (beta)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta radiation (β-radiation or β (beta)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call